These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23673553)

  • 1. Rapid assessment of homogeneity and stability of amorphous solid dispersions by atomic force microscopy--from bench to batch.
    Lauer ME; Siam M; Tardio J; Page S; Kindt JH; Grassmann O
    Pharm Res; 2013 Aug; 30(8):2010-22. PubMed ID: 23673553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic force microscopy-based screening of drug-excipient miscibility and stability of solid dispersions.
    Lauer ME; Grassmann O; Siam M; Tardio J; Jacob L; Page S; Kindt JH; Engel A; Alsenz J
    Pharm Res; 2011 Mar; 28(3):572-84. PubMed ID: 21046435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.
    Yang Z; Nollenberger K; Albers J; Craig D; Qi S
    Pharm Res; 2015 Apr; 32(4):1210-28. PubMed ID: 25270572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compositional analysis of low quantities of phase separation in hot-melt-extruded solid dispersions: a combined atomic force microscopy, photothermal fourier-transform infrared microspectroscopy, and localised thermal analysis approach.
    Qi S; Belton P; Nollenberger K; Gryczke A; Craig DQ
    Pharm Res; 2011 Sep; 28(9):2311-26. PubMed ID: 21607778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of processing on the surface physical stability of amorphous solid dispersions.
    Yang Z; Nollenberger K; Albers J; Moffat J; Craig D; Qi S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):897-908. PubMed ID: 25111184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
    Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
    Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Solid Physical State of API and Its Distribution in Pharmaceutical Hot Melt Extrudates Using Terahertz Raman Imaging.
    Ibrahim M; Zhang J; Repka M; Chen R
    AAPS PharmSciTech; 2019 Jan; 20(2):62. PubMed ID: 30627934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z; Nollenberger K; Albers J; Qi S
    Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Numerical simulation of hot-melt extrusion processes for amorphous solid dispersions using model-based melt viscosity.
    Bochmann ES; Steffens KE; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2018 Mar; 124():34-42. PubMed ID: 29221654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
    Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
    Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT; Lee PI
    J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the use of low quantities of functional additives to control drug release from hot melt extruded solid dispersions for poorly soluble drug delivery.
    Alqahtani F; Belton P; Ward A; Asare-Addo K; Qi S
    Int J Pharm; 2020 Apr; 579():119172. PubMed ID: 32097683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step continuous extrusion process for the manufacturing of solid dispersions.
    Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.